HAT ‐ PCR is non‐inferior to NGS when quantifying measurable residual disease for myeloma

British Journal of Haematology 2026 Open access

Read full text

Authors: Elizabeth Hughes, Piers Blombery, Sushmitha Kannan, Tiffany T. Khong, Andrew Spencer, Alexander A. Morley

DOI: 10.1111/bjh.70478

Cited by: 1

References: 14

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Malaria Research and Control Myeloproliferative Neoplasms: Diagnosis and Treatment

References 14